Skip to main content Skip to primary navigation

Chiralyst® Rh639

Chiralyst® Rh639

[((R,R)-2-Amino-1,2-diphenylethyl)[(4-tolyl)sulfonyl]amido](chloro)pentamethylcyclopentadienylrhodium(I)

CAS Number: 223392-99-2

Chemical properties

Chemical formula

C31H36N2ClO2SRh

Empirical formula

Rh[(R,R)-TsDPEN](C5Me5)Cl

Molecular weight

639.06

Metal

Rh

Theoretical metal content

16

Physical state

crystalline

Color

orange brown

Metal purity

99.9

Your contact person

Phil Chalabi

T: +1 (918) 266 4826
Email

Chinmay Pandya

T: +91 9867662944
Email

Ula Rao

T: +86 (21) 2411 6843
Email

Heidi Heuser

T: +49 (6181) 59 2413
Email

Yukari Nakada

T: +81 90 9018 6731
Email

Heidi Heuser

T: +49 (6181) 59 2413
Email

Applications & references

Description

Asymmetric reduction of α-sulfonyloxy acetophenone compound yielding an optically active 2-sulfonyloxy-1-phenylethanol derivative with high enantiomer excess.

Reference: WO2008 054155

 

Asymmetric synthesis of ß-amino alcohols by rhodium catalyzed transfer hydrogenation of α-keto imines.

Reference: Tetrah. Asym. 2010, 21, 2244 (DOI: 10.1016/j.tetasy.2010.07.004)

 

One pot synthesis of sterically active epoxides starting from α-chloroacetophenones including a asymmetric transfer hydrogenation step.

Reference: Tetrah.  2004, 60, 7411 (DOI: 10.1016/j.tet.2004.06.076)

 

Synthesis of optically active styrene oxides by asymmetric reduction of 2-chloroacetophenones.

Reference: Org. Lett. 2002, 4, 4373 (DOI: 10.1021/ol020213o)

 

Enantioselective preparation of cyclic sulfamidates by using asymmetric transfer hydrogenation.

Reference: Org. Lett. 2010, 12, 4184 (DOI: 10.1021/ol1017905)

 

Asymmetric transfer hydrogenation of α-aminoalkyl α’-chloromethylketones yielding useful intermediates for the total synthesis of inhibitors of HIV protease and ß-secretase in Alzheimer disease.

Reference: J. Org. Chem. 2004, 69, 7391 (DOI: 10.1021/jo0491455)

Related products

Chiralyst® P310

12245-39-5Rh(cod)(acac)

Precious Metals Chemistry

PMC

Chiralyst® P407

35138-22-8[Rh(cod)2]BF4

Precious Metals Chemistry

PMC

Chiralyst® P468

99326-34-8[Rh(cod)2]CF3SO3

Precious Metals Chemistry

PMC

Chiralyst® P461

12257-42-0[Rh(nbd)Cl]2

Precious Metals Chemistry

PMC

Chiralyst® P493

12092-47-6[Rh(cod)Cl]2

Precious Metals Chemistry

PMC

Chiralyst® P374

36620-11-8[Rh(nbd)2]BF4

Precious Metals Chemistry

PMC

Chiralyst® P618

12354-85-7[Rh(C5Me5)Cl2]2

Precious Metals Chemistry

PMC

Chiralyst® Rh640

219944-99-7Rh[(S,S)-TsDPEN](C5Me5)Cl

Precious Metals Chemistry

PMC

Chiralyst® Rh1228

673458-88-3[Rh(SL-W001-1)(cod)]BF4

Precious Metals Chemistry

PMC

Chiralyst® Rh840

673458-86-1[Rh(SL-J002-1)(cod)]BF4

Precious Metals Chemistry

PMC

Chiralyst® P1182

404573-66-6[Rh(cod)2]BArF

Precious Metals Chemistry

PMC

Chiralyst® Rh1351

827596-70-3[Rh(SL-M004-1)(cod)]BF4

Precious Metals Chemistry

PMC

Chiralyst® Rh1010

827596-68-9[Rh(SL-T002-1)(cod)]BF4

Precious Metals Chemistry

PMC

Chiralyst® Rh1119

673458-82-7[Rh(SL-M001-1)(cod)]BF4

Precious Metals Chemistry

PMC

Chiralyst® Rh986

673458-84-9[Rh(SL-T001-1)(cod)]BF4

Precious Metals Chemistry

PMC

Chiralyst® Rh660

228121-39-9[Rh[(R,R)-EtDuPhos](cod)]BF4

Precious Metals Chemistry

PMC

Chiralyst® Rh604

210057-23-1[Rh[(R,R)-MeDuPhos](cod)]BF4

Precious Metals Chemistry

PMC

Chiralyst® Rh605

205064-10-4[Rh[(S,S)-MeDuPhos](cod)]BF4

Precious Metals Chemistry

PMC

Chiralyst® Rh804

528565-84-6[Rh[(R,R)-Ph-BPE](cod)]BF4

Precious Metals Chemistry

PMC